Breaking News

KKR to Acquire All Shares in Bushu Pharma

Aims to accelerate Bushu’s growth and further position it as a leading CDMO for the pharmaceuticals market in Japan and worldwide.

Author Image

By: Charlie Sternberg

Associate Editor

KKR, a global investment firm, and Bushu Pharmaceuticals Ltd.  have signed a definitive agreement under which KKR will acquire all shares in Bushu Pharma from BPEA EQT.   Following the transaction’s completion, KKR aims to accelerate Bushu Pharma’s growth and further position the company as a leading contract development and manufacturing organization (CDMO) for the pharmaceuticals market in Japan and worldwide.   Founded in 1998, Bushu Pharma is a leading pure-play pharmaceutical CDMO based...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters